Skip to main content
. 2012 Sep 28;18(36):5042–5050. doi: 10.3748/wjg.v18.i36.5042

Figure 1.

Figure 1

Systemic blood D(-)-lactate levels in the mouse model of fulminant hepatic failure and controls. Systemic blood D (-)-lactate levels 2, 6, 9, 12 and 24 h after injection in D-galactosamine (GalN)/lipopolysaccharide (LPS)-treated mice, and 6 h after injection in the saline, GalN, LPS, tumor necrosis factor alpha (TNF-α), anti-TNF-α immunoglobulin G antibody-pretreated groups. n = 5 rats for each time point. NS: Normal saline; FHF: Fulminant hepatic failure. The level of significance was set at aP < 0.05, bP < 0.01 vs baseline (NS group). Data are reported as the mean ± SD.